Investing

The U.S. Securities and Exchange Commission this week issued fraud charges against cannabis company American Patriot Brands, its CEO, and five others for allegedly funneling investor funds into personal accounts and expenses.

The cannabis B2B tech firm LeafLink announced it raised $100 million in its Series D financing round.

Canopy Growth Corporation announced it will look to fast-track its expansion from Canada into the U.S. cannabis market. 

DEA pharmaceutical cannabis license-holder Biopharmaceutical Research Company has raised $20 million in its Series A funding round. 

Longtime cannabis advocate, author, entrepreneur, and investor Steve DeAngelo published an op-ed this week that decries the cannabis industry’s drive for “scale” and calls for the widespread return of small, artisan operators.

As cannabis industry operations become more and more costly, female-led cannabis companies are finding it more difficult to raise capital than male-owned firms.

Researchers at California Polytechnic State University and The University of New Mexico found that stock market returns for major pharmaceutical firms were 1.5-2% lower 10 days after the passage of cannabis legalization reforms.

Two people were convicted in a cannabis-and-cattle Ponzi scheme last week on charges including conspiracy to commit money laundering, conspiracy to commit wire fraud, and five counts of wire fraud; they are facing multiple decades in prison for the $650 million scam.

Cannabis equity funding has all but dried up — unfortunately, it’s the small to midsize cannabis companies who will be suffering for it.

A recent memo from the Biden Administration suggests that White House applicants who have invested in the legal cannabis industry may be denied security clearances.

Ascend Wellness Holdings Inc. is calling off the deal to take over MedMen New York due to concerns about MedMen’s allegedly ‘deteriorating’ assets.

The global medical cannabis industry is predicted to reach a value of $24.86 billion by 2027, according to a new report.

George Allen is Chairman of the Board for California-based Lowell Farms and founder of the cannabis industry investment firm Geronimo Capital LLC.

Connecticut’s quasi-public venture capital arm Connecticut Innovations has invested in 1906, a low-dose medical cannabis company.

Cresco Labs agreed to acquire Columbia Care Inc. in a $2 billion acquisition deal that will see the firm become the largest multi-state operator in the U.S.

Aurora Cannabis Inc. has acquired Thrive Cannabis’ parent company TerraFarma Inc. in a deal worth $38 million.

A recent survey by the National Cannabis Industry Association and Whitney Economics found that 37% of cannabis businesses in the U.S. are not profitable.

TerrAscend, a Canadian cannabis company, has finished its acquisition of Gage Growth Corp in a $545 million deal.

Green Thumb Industries Inc. has closed on its acquisition of LeafLine Industries, which owns one of Minnesota’s two vertical licenses, giving GTI a national presence in 15 states.